Teladoc Health Q1 EPS Estimate Decreased by William Blair

Teladoc Health, Inc. (NYSE:TDOC) – Equities research analysts at William Blair reduced their Q1 2025 earnings per share (EPS) estimates for Teladoc Health in a research note issued to investors on Wednesday, February 26th. William Blair analyst R. Daniels now anticipates that the health services provider will earn ($0.31) per share for the quarter, down from their previous forecast of ($0.27). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share. William Blair also issued estimates for Teladoc Health’s Q3 2025 earnings at ($0.18) EPS, Q4 2025 earnings at ($0.18) EPS and FY2025 earnings at ($0.88) EPS.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million.

A number of other analysts also recently weighed in on TDOC. Piper Sandler decreased their target price on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Royal Bank of Canada increased their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. The Goldman Sachs Group decreased their target price on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Monday. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Finally, Bank of America increased their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research report on Wednesday, February 12th. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and a consensus price target of $11.26.

Teladoc Health Stock Performance

Teladoc Health stock opened at $9.21 on Monday. The company has a market capitalization of $1.58 billion, a P/E ratio of -1.60 and a beta of 1.05. The business has a 50 day moving average of $10.63 and a 200-day moving average of $9.61. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $15.95.

Hedge Funds Weigh In On Teladoc Health

A number of large investors have recently modified their holdings of TDOC. Point72 Asset Management L.P. lifted its holdings in shares of Teladoc Health by 57.8% in the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after purchasing an additional 3,063,172 shares in the last quarter. Maple Rock Capital Partners Inc. lifted its holdings in shares of Teladoc Health by 189.5% in the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock worth $32,369,000 after purchasing an additional 2,331,000 shares in the last quarter. Two Sigma Investments LP bought a new position in shares of Teladoc Health in the 4th quarter worth $18,348,000. Two Sigma Advisers LP lifted its holdings in shares of Teladoc Health by 213.0% in the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock worth $20,532,000 after purchasing an additional 1,537,094 shares in the last quarter. Finally, Vanguard Group Inc. lifted its stake in Teladoc Health by 5.9% during the 4th quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock valued at $167,830,000 after acquiring an additional 1,029,829 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.